AstraZeneca and its development partner Amgen announced that the FDA has granted Breakthrough Therapy Designation (BTD) for tezepelumab in patients with severe asthma, without an eosinophilic ...
When you first start coughing, feel fatigued, and notice a low-grade fever, it can be hard to determine whether you have the common cold or bronchitis. A cold can potentially turn into bronchitis.